Dr. Christoph Massner

Christoph is a key investor at Earlybird Health, where he was promoted to Partner. He focuses on the full investment lifecycle, from sourcing and due diligence to deal execution and portfolio support, with a specific interest in digital health, medical technologies, diagnostics, biopharma, and R&D platforms. He is known for articulating how data and AI create value in patient care and product development, bringing a commercial-led mindset to investments. earlybird+2

His expertise extends to board-level leadership, currently serving as a Board Director for Hilo (by Aktiia), Ariceum Therapeutics, and Noscendo GmbH, and as a Board Observer for Shape Memory Medical Inc. and Alesi Surgical Ltd. These roles highlight his commitment to guiding innovative health companies through various stages of development. frontiers+2